16739316

Source:http://linkedlifedata.com/resource/pubmed/id/16739316

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0077375, umls-concept:C0205179, umls-concept:C0376358, umls-concept:C1285530
pubmed:issue	1B
pubmed:dateCreated	2006-6-2
pubmed:abstractText	A phase II study with trofosfamide in hormone-refractory prostate cancer was conducted to test the palliative efficacy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8102988
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen, http://linkedlifedata.com/resource/pubmed/chemical/trofosfamide
pubmed:status	MEDLINE
pubmed:issn	0250-7005
pubmed:author	pubmed-author:NikkanenVV, pubmed-author:SalminenE KEK, pubmed-author:SundströmJJ
pubmed:issnType	Print
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	539-42
pubmed:meshHeading	pubmed-meshheading:16739316-Aged, pubmed-meshheading:16739316-Aged, 80 and over, pubmed-meshheading:16739316-Antineoplastic Agents, Alkylating, pubmed-meshheading:16739316-Cyclophosphamide, pubmed-meshheading:16739316-Humans, pubmed-meshheading:16739316-Male, pubmed-meshheading:16739316-Middle Aged, pubmed-meshheading:16739316-Palliative Care, pubmed-meshheading:16739316-Prostate-Specific Antigen, pubmed-meshheading:16739316-Prostatic Neoplasms
pubmed:articleTitle	Palliative chemotherapy with trofosfamide in advanced prostate cancer.
pubmed:affiliation	Department of Radiotherapy and Oncology, Turku University Hospital, Finland. eevsal@utu.fi
pubmed:publicationType	Journal Article